bioMérieux S.A. (EPA:BIM)
93.30
-1.45 (-1.53%)
Nov 6, 2026, 5:35 PM CET
bioMérieux Employees
As of December 31, 2025, bioMérieux had 15,226 total employees, including 14,562 full-time and 664 part-time employees. The number of employees increased by 472 or 3.20% compared to the previous year. That makes bioMérieux the 2,368th largest employer in the world and 74th in France.
Employees
15,226
Change (1Y)
472
Growth (1Y)
3.20%
Revenue / Employee
€267,933
Profits / Employee
€31,059
Market Cap
10.98B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15,226 | 472 | 3.20% | 14,562 | 664 |
| Dec 31, 2024 | 14,754 | 772 | 5.52% | 14,147 | 607 |
| Dec 31, 2023 | 13,982 | 847 | 6.45% | 13,409 | 573 |
| Dec 31, 2022 | 13,135 | 756 | 6.11% | 12,557 | 578 |
| Dec 31, 2021 | 12,379 | -245 | -1.94% | 12,084 | 295 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 213,909 |
| emeis Société anonyme | 84,600 |
| Sanofi | 74,846 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,000 |
| Sartorius Stedim Biotech | 10,483 |
| Virbac | 6,442 |
| Ipsen | 5,535 |
bioMérieux News
- 3 days ago - bioMerieux downgraded to Hold from Buy at Kepler Cheuvreux - TheFly
- 4 days ago - bioMerieux price target raised to EUR 84 from EUR 71.60 at JPMorgan - TheFly
- 5 days ago - BioMerieux Records 9% Sales Growth In Q3 Amid New Test Launches; Reaffirms 2026 Guidance - Nasdaq
- 5 days ago - bioMérieux Earnings Call Transcript: Q3 2026 - Transcripts
- 5 days ago - bioMérieux Earnings release: Q3 2026 - Filings
- 5 days ago - Biomérieux third-quarter sales grew more than expected - Reuters
- 11 days ago - bioMerieux upgraded to Buy from Hold at Deutsche Bank - TheFly
- 17 days ago - Consensus Price Target for bioMérieux S.A. - Depositary Receipt Decreased by 24.45% to $9.77 - Nasdaq